Alcohol-Dependency Drug Causing Complications
Nearly 200 people treated with an injectable drug for alcohol dependence have suffered complications such as abscesses that required surgery to drain, the Food and Drug Administration said.
Vivitrol, made by Alkermes Inc. and marketed by Cephalon Inc., is an extended-release form of generic naltrexone that is used in patients being treated for alcohol dependence when the patients can abstain from drinking alcohol before receiving the drug therapy.
The FDA has received 196 reports of Vivitrol patients developing swelling, pain, bleeding, and other complications from the injections. Sixteen patients required surgery to drain the injection site or to repair damaged tissue, the FDA said.
Doctors are being advised to make sure they are properly administering Vivitrol injections and to closely monitor patients for swelling or other worsening reactions following treatment. Vivitrol may also result in side effects including nausea, headache, and diarrhea.
Related posts:
- Depression Drug Norpramin Linked to Fatal Heart Complications, FDA Warns The Food and Drug Administration and drugmaker Sanofi-Aventis are telling...
- Weight-Loss Drug Meridia Linked to Reports of Heart Complications, FDA Warns The Food and Drug Administration said early results from a...
- LASIK: Popular Vision-Correction Surgery Linked to Blindness, Other Complications LASIK, the form of laser vision correction surgery that more...
- Lawsuit Accuses Antipsychotic Zyprexa of Causing Diabetes, Weight Gain An Illinois woman has joined the growing ranks of people...
- Levaquin and Cipro: Potent Antibiotics Tied to Painful Tendon Ruptures, Other Complications Levaquin and Cipro are the brand names for two powerful...
Permalink Tags: alcohol dependancy, fda, naltrexone, vivitrol
